The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
98011597 9801159 7 F 20121218 20160805 20140107 20160811 EXP US-PFIZER INC-2014001232 PFIZER 59.00 YR F Y 65.77000 KG 20160811 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
98011597 9801159 1 PS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 100 MG, 1X/DAY 21992 100 MG PROLONGED-RELEASE TABLET QD
98011597 9801159 2 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 150 MG, 1X/DAY 21992 150 MG PROLONGED-RELEASE TABLET QD
98011597 9801159 3 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 100 MG, DAILY 21992 100 MG PROLONGED-RELEASE TABLET
98011597 9801159 4 SS PRISTIQ EXTENDED-RELEASE DESVENLAFAXINE SUCCINATE 1 Oral 200 MG, DAILY N12688 21992 200 MG PROLONGED-RELEASE TABLET
98011597 9801159 5 C ROZEREM RAMELTEON 1 8 MG, 1X/DAY (QHS) 0 8 MG QD
98011597 9801159 6 C BENICAR/HCTZ 20/12.5 2 UNK 0
98011597 9801159 7 C DEXILANT DEXLANSOPRAZOLE 1 60 MG, 1X/DAY 0 60 MG QD
98011597 9801159 8 C CADUET AMLODIPINE BESYLATEATORVASTATIN CALCIUM 1 5 MG, 1X/DAY 0 5 MG QD
98011597 9801159 9 C MELOXICAM. MELOXICAM 1 7.5 MG, 1X/DAY 0 7.5 MG QD
98011597 9801159 10 C XANAX ALPRAZOLAM 1 1 MG, TWICE DAILY, AS NEEDED 0 1 MG
98011597 9801159 11 C VYVANSE LISDEXAMFETAMINE DIMESYLATE 1 70 MG, 1X/DAY 0 70 MG QD
98011597 9801159 12 C NEURONTIN GABAPENTIN 1 300 MG, QHS, AS NEEDED 0 300 MG
98011597 9801159 13 C SEROQUEL QUETIAPINE FUMARATE 1 100 MG, 1X/DAY (ONCE AT NIGHT TIME) 0 100 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
98011597 9801159 1 Depression
98011597 9801159 5 Insomnia
98011597 9801159 10 Anxiety
98011597 9801159 11 Attention deficit/hyperactivity disorder
98011597 9801159 12 Pain
98011597 9801159 13 Depression

Outcome of event

Event ID CASEID OUTC COD
98011597 9801159 HO
98011597 9801159 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
98011597 9801159 Anxiety
98011597 9801159 Breast mass
98011597 9801159 Crying
98011597 9801159 Depression
98011597 9801159 Drug withdrawal syndrome
98011597 9801159 Feeling abnormal
98011597 9801159 Intentional product misuse
98011597 9801159 Renal neoplasm
98011597 9801159 Suicidal ideation
98011597 9801159 Suicide attempt

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
98011597 9801159 1 20120716 20130114 0
98011597 9801159 2 20130115 201311 0
98011597 9801159 3 2013 2013 0
98011597 9801159 4 2013 0
98011597 9801159 5 20101016 0
98011597 9801159 10 20120105 0
98011597 9801159 11 20101016 0
98011597 9801159 12 20120404 0